Post-treatment weight regain following discontinuation of GLP-1 receptor agonist therapy
Finally, both the MCT-KD and KS protocols attenuated the stress-induced decrease of BDNF (brain-derived neurotrophic factor) in the hippocampus (p 0.05)
Adverse reactions with WEGOVY treatment in pediatric patients aged 12 years and older were generally similar to those reported in adults
This is an area of growing interest
[1] This metabolic pathway means semaglutide does not compete with the vast majority of medicationsincluding antibioticsthat are processed through hepatic enzyme systems, reducing the potential for metabolic drug interactions
Runa Salim Jul 21, 2023 2 min read Updated: Aug 29, 2023 In response to a nationwide shortage of GLP -1 RAs, a National Patient Safety Alert was recently broadcasted to provide further background, clinical information, and actions for providers